Cargando…

Tilapia skin peptides, a by-product of fish processing, ameliorate DSS-induced colitis by regulating inflammation and inhibiting apoptosis

Intestinal bowel disease (IBD) has always been tough to treat, therefore researchers are struggle to look for treatments that are safe, low cost, and effective. Food-derived peptides are thought to have anti-inflammatory and antioxidant properties, but they have not been studied in depth in the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jiahui, Li, Lixiang, Zhao, Dong, Wang, Xia, Xia, Yanan, Li, Bing, Liu, Chang, Zuo, Xiuli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525210/
https://www.ncbi.nlm.nih.gov/pubmed/36185687
http://dx.doi.org/10.3389/fnut.2022.988758
_version_ 1784800658208063488
author Gao, Jiahui
Li, Lixiang
Zhao, Dong
Wang, Xia
Xia, Yanan
Li, Bing
Liu, Chang
Zuo, Xiuli
author_facet Gao, Jiahui
Li, Lixiang
Zhao, Dong
Wang, Xia
Xia, Yanan
Li, Bing
Liu, Chang
Zuo, Xiuli
author_sort Gao, Jiahui
collection PubMed
description Intestinal bowel disease (IBD) has always been tough to treat, therefore researchers are struggle to look for treatments that are safe, low cost, and effective. Food-derived peptides are thought to have anti-inflammatory and antioxidant properties, but they have not been studied in depth in the treatment of IBD. Based on this, we explored the effect of tilapia skin peptides (TSPs) on the remission of colitis in the present study. Colonic epithelial cell lines CT-26 and HT-29 were co-treated with lipopolysaccharide (LPS) and TSPs for 12 h. Cell viability was assessed by CCK8 assay. Dextran sulfate sodium (DSS)-induced colitis model was established and 100 mg/kg TSPs were oral administered at the same time as DSS intervention. Colonic mucosal barrier function was assessed by western blotting. The inflammatory responses were evaluated by quantitative real-time PCR along with ELISA, respectively. Apoptosis was investigated by TUNEL and flow cytometry. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to characterize peptides composition of TSPs. It was found that TSPs significantly inhibit LPS-induced inflammation and apoptosis in vitro without affecting cell viability. Moreover, the upregulation and activation of Caspase-3 and Caspase-8 were also reversed by TSPs. Subsequently, in vivo experiments demonstrated that TSPs can attenuate DSS induced colitis, manifested by a decrease in weight loss and colon shortening. The expression of ZO-1 and occluding were significantly increased, and the pro-inflammatory cytokines were down-regulated. Meanwhile, TSPs alleviated DSS-induced apoptosis and reduced the expressions of Caspase-3 and Caspase-8. Finally, we found that TSPs were composed of 51 short peptides, and 12 of them were predicted to have significant biological activity. Collectively, this study suggested that TSPs can alleviate colon damage caused by foreign stimuli via inhibiting inflammation and apoptosis which indicated that it has great potential value for the treatment of IBD.
format Online
Article
Text
id pubmed-9525210
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95252102022-10-01 Tilapia skin peptides, a by-product of fish processing, ameliorate DSS-induced colitis by regulating inflammation and inhibiting apoptosis Gao, Jiahui Li, Lixiang Zhao, Dong Wang, Xia Xia, Yanan Li, Bing Liu, Chang Zuo, Xiuli Front Nutr Nutrition Intestinal bowel disease (IBD) has always been tough to treat, therefore researchers are struggle to look for treatments that are safe, low cost, and effective. Food-derived peptides are thought to have anti-inflammatory and antioxidant properties, but they have not been studied in depth in the treatment of IBD. Based on this, we explored the effect of tilapia skin peptides (TSPs) on the remission of colitis in the present study. Colonic epithelial cell lines CT-26 and HT-29 were co-treated with lipopolysaccharide (LPS) and TSPs for 12 h. Cell viability was assessed by CCK8 assay. Dextran sulfate sodium (DSS)-induced colitis model was established and 100 mg/kg TSPs were oral administered at the same time as DSS intervention. Colonic mucosal barrier function was assessed by western blotting. The inflammatory responses were evaluated by quantitative real-time PCR along with ELISA, respectively. Apoptosis was investigated by TUNEL and flow cytometry. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to characterize peptides composition of TSPs. It was found that TSPs significantly inhibit LPS-induced inflammation and apoptosis in vitro without affecting cell viability. Moreover, the upregulation and activation of Caspase-3 and Caspase-8 were also reversed by TSPs. Subsequently, in vivo experiments demonstrated that TSPs can attenuate DSS induced colitis, manifested by a decrease in weight loss and colon shortening. The expression of ZO-1 and occluding were significantly increased, and the pro-inflammatory cytokines were down-regulated. Meanwhile, TSPs alleviated DSS-induced apoptosis and reduced the expressions of Caspase-3 and Caspase-8. Finally, we found that TSPs were composed of 51 short peptides, and 12 of them were predicted to have significant biological activity. Collectively, this study suggested that TSPs can alleviate colon damage caused by foreign stimuli via inhibiting inflammation and apoptosis which indicated that it has great potential value for the treatment of IBD. Frontiers Media S.A. 2022-09-08 /pmc/articles/PMC9525210/ /pubmed/36185687 http://dx.doi.org/10.3389/fnut.2022.988758 Text en Copyright © 2022 Gao, Li, Zhao, Wang, Xia, Li, Liu and Zuo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Gao, Jiahui
Li, Lixiang
Zhao, Dong
Wang, Xia
Xia, Yanan
Li, Bing
Liu, Chang
Zuo, Xiuli
Tilapia skin peptides, a by-product of fish processing, ameliorate DSS-induced colitis by regulating inflammation and inhibiting apoptosis
title Tilapia skin peptides, a by-product of fish processing, ameliorate DSS-induced colitis by regulating inflammation and inhibiting apoptosis
title_full Tilapia skin peptides, a by-product of fish processing, ameliorate DSS-induced colitis by regulating inflammation and inhibiting apoptosis
title_fullStr Tilapia skin peptides, a by-product of fish processing, ameliorate DSS-induced colitis by regulating inflammation and inhibiting apoptosis
title_full_unstemmed Tilapia skin peptides, a by-product of fish processing, ameliorate DSS-induced colitis by regulating inflammation and inhibiting apoptosis
title_short Tilapia skin peptides, a by-product of fish processing, ameliorate DSS-induced colitis by regulating inflammation and inhibiting apoptosis
title_sort tilapia skin peptides, a by-product of fish processing, ameliorate dss-induced colitis by regulating inflammation and inhibiting apoptosis
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525210/
https://www.ncbi.nlm.nih.gov/pubmed/36185687
http://dx.doi.org/10.3389/fnut.2022.988758
work_keys_str_mv AT gaojiahui tilapiaskinpeptidesabyproductoffishprocessingamelioratedssinducedcolitisbyregulatinginflammationandinhibitingapoptosis
AT lilixiang tilapiaskinpeptidesabyproductoffishprocessingamelioratedssinducedcolitisbyregulatinginflammationandinhibitingapoptosis
AT zhaodong tilapiaskinpeptidesabyproductoffishprocessingamelioratedssinducedcolitisbyregulatinginflammationandinhibitingapoptosis
AT wangxia tilapiaskinpeptidesabyproductoffishprocessingamelioratedssinducedcolitisbyregulatinginflammationandinhibitingapoptosis
AT xiayanan tilapiaskinpeptidesabyproductoffishprocessingamelioratedssinducedcolitisbyregulatinginflammationandinhibitingapoptosis
AT libing tilapiaskinpeptidesabyproductoffishprocessingamelioratedssinducedcolitisbyregulatinginflammationandinhibitingapoptosis
AT liuchang tilapiaskinpeptidesabyproductoffishprocessingamelioratedssinducedcolitisbyregulatinginflammationandinhibitingapoptosis
AT zuoxiuli tilapiaskinpeptidesabyproductoffishprocessingamelioratedssinducedcolitisbyregulatinginflammationandinhibitingapoptosis